Manpower Software PLC
09 May 2005
MANPOWER SOFTWARE PLC
(the "Company")
ALLIANCE AGREEMENT WITH SPECIALIST COMPUTER CENTRES PLC ("SCC")
Manpower Software plc is pleased to announce that it has signed an Alliance
Agreement with SCC, the pan-European technology integrator and services
provider, for the resale of Manpower Software's MAPS Workforce Planning and Duty
Rostering software in the UK. The Agreement will initially focus on sales of
MAPS Taskforce Duty Rostering software to the UK National Health Service ("NHS
").
SCC is the technology enabler brand of Europe's largest independent technology
group, which employs over 6,000 employees, across a pan-European network of 65
offices located in key cities, generating a turnover approaching three billion
euros.
In the UK, SCC has a market leading public sector division that spans six
verticals including healthcare, education and local government. SCC's products
and services are directly aligned to the modernising Government agenda. For
example, ahead of the implementation of the National Programme for IT, and an
outstanding testimonial for the programme, SCC provided a leading technology
solution for the Lancashire Teaching Hospital NHS Trust that releases clinician
time and is delivering tangible improvements in patient care.
SCC is a G-CAT (Government IT Catalogue) approved supplier for computer software
sales to the NHS. Manpower Software has been approved as an accredited
sub-contractor to SCC by the Office of Government Commerce, which is responsible
for G-CAT through its Executive Agency OGCbuying.solutions.
Manpower Software anticipates two important benefits from the Agreement:
• first, an increase in orders for MAPS Taskforce as SCC introduces MAPS to
its extensive NHS user base; and
• second, faster order intake and a shortening of the average sales cycle,
since customers will be able to purchase MAPS Taskforce from SCC on a
non-competitive basis.
MAPS Taskforce Duty Rostering cost-effectively solves two critical problems for
the UK NHS: high expenditure on bank and agency nurse staffing and the
considerable front-line staff effort needed to create rosters. These problems
are now receiving significant attention internally within NHS Trusts and
government. In addition, correct rostering not only reduces clinical risk and
allows better patient care, but also improves staff morale and increases
retention levels of existing staff. The Company has a unique and strong product
offering in this area.
Paul Scandrett, Director Strategic Markets for Manpower Software, commented:
"MAPS Taskforce can help reduce the use of agency staff significantly, as
already proven in pilot studies that we have carried out recently with NHS
Hospital Trusts. Because costs of agency staff to an NHS Acute Trust may run
into many millions of pounds a year, improving rostering and cutting the use of
agency staff is a high priority for many Trust Boards. For this reason we
believe that SCC's NHS customers will respond enthusiastically to the benefits
of MAPS Taskforce."
Sharon Hurd, Head of Healthcare at SCC, said:
"SCC is totally supportive of the NHS National Programme for IT's objectives and
is already delivering proven services and solutions. Through the selection of
Manpower Software as a partner, we continue to expand and deepen our offer to
the healthcare sector.
"The NHS has the largest nomadic workforce in the country and extensively uses
temporary employment and recruitment agencies. Improving patient care through
best maximising the resources available to it, whilst seeking to create
administrative efficiencies, is a key priority. Manpower Software's MAPS
Taskforce solution will aid the effective utilisation of clinical staff to
ensure front line care is available where and when it is most needed."
Enquiries:
Manpower Software plc
Simon Thorne, Finance Director 020 7389 9500
Shore Capital
Alex Borrelli 020 7408 4090
Dated 9 May 2005
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.